Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189

Summary

This will be a dose block-randomized, double-blind, active and placebo controlled, single and multiple dosing, dose-escalation study to evaluate tolerability, safety and pharmacokinetic / pharmacodynamic characteristics. Adverse events, physical examinations, vital signs, ECG and laboratory tests will be conducted for safety/tolerability evaluation and serial blood samples and urine collections for pharmacokinetic and pharmacodynamic evaluations will be conducted at specified time points.

Timeline

Start

2011-06

Primary completion

2013-01

Completion

2013-01

Drugs

Indications